ClinicalTrials.gg
Sign In
CompletedNCT03772184Updated Feb 22, 2022

Modified Cervical Inversion During CS in Placenta Previa

An interventional study of Cervical inversion in Placenta Previa, sponsored by Aljazeera Hospital. Completed at 1 site in Egypt. Open to female participants aged 22 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-22.

Sponsored by Aljazeera Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
22 Years to 40 Years
Sex
Female
01

Study summary

There is an increasing rates of placenta previa nowadays

Read the detailed description

several techniques were described to control bleeding .

02

Conditions studied

  • Placenta Previa

Browse trials for

03

In context

Placenta Previa

80 studies on the registry are indexed under Placenta Previa; 17 are open to participants now.

This study's enrollment of 240 is above the median of 109 across 45 interventional studies indexed under Placenta Previa.

Browse Placenta Previa studies →

Lead sponsor

Aljazeera Hospital is the lead sponsor of 64 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant women 38 weeks or more with placenta previa

Exclusion criteria

Exclusion Criteria:

  • pregnant ladies with normally implanted placenta or placenta accreat , increta or percreta
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
240 participants (actual)

Study arms

  • Active comparator
    cervical inversion

    Procedure: Cervical inversion

  • No intervention
    no cervical inversion

Interventions

  • ProcedureCervical inversion

    inverting the cervical lip after delivery

06

What researchers measure

Primary outcomes

  1. The number of women whose placental bed bleeding will be controlled by cervical inversion cervical inversion

    how can the cervical inversion technique controls the placental bed bleeding

    Time frame: within an hour

07

Study locations

1 site
  • Algazeerah and helwan university
    Giza, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2019 to primary completion in May 2019, 4 months.

Of 23 interventional studies with no phase under Placenta Previa, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's 4 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2018
First posted
Dec 11, 2018
StartActual
Jan 10, 2019
Primary completionActual
May 12, 2019
CompletionActual
May 15, 2019
Last update
Feb 22, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03772184
Lead sponsor
Aljazeera Hospital
Collaborators
Suez Canal University
Responsible party
Mahmoud Alalfy (Lecturer Obstetrics and Gyneology , National Research Centre, Aljazeera Hospital) — Principal investigator
First posted
Dec 11, 2018
Start date
Jan 10, 2019
Primary completion
May 12, 2019
Completion
May 15, 2019
Last update
Feb 22, 2022

Study contacts

Mahmoud Alalfy, PhD
principal investigator · National research centre , Aljazeerah hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Placenta Previa →

Other studies from this sponsor

Aljazeera Hospital

Start the discussion